chrisvoncsefalvay/vaers-outcomes huggingface dataset:
break outs under arm area/flare up; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH (break outs under arm area/flare up) and FATIGUE (Fatigue) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Hidradenitis suppurativa and Rheumatoid arthritis.    No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced RASH (break outs under arm area/flare up) and FATIGUE (Fatigue). At the time of the report, RASH (break outs under arm area/flare up) had not resolved and FATIGUE (Fatigue) outcome was unknown.            No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
This spontaneous report as received from a health care worker refers to a patient of unknown age and unknown gender. The patient's pertinent medical history was not reported. On 17-NOV-2014 the patient was vaccinated with VARIVAX (Merck) (dose, frequency and route were not reported) that underwent a supported temperature excursion. No adverse experiences reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This case is linked to case # 1501USA001374 (same reporter link). Additional information has been requested.
I received an MMR shot on December 19, 2008 as part of my registration requrements.  As of today, there remains a very tender area on my right arm where the vaccine was given.  There is a lump about the size of a half-dollar and the skin around the area is warm.
urticarial rash, bluish discoloration of hands & feet w/swelling occuring approx 10 days p/MMR inj;
numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness). At the time of the report, HYPOAESTHESIA (numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment drugs were reported
Individual inadvertently given vaccine at age 17 whereas indicated and approved for individuals aged 18+
Injection site soreness 4 days, chills 5min, fatigue 2 days, drop blood pressure, light headed 2day--extreme 10 min, heavy sweating 10 min, glazed eyes, NO fever,
Rash on thigh - still hasn't resolved by now, 14 months after immunization.  Thought it was eczema but too median for eczema.
Initial report received from a health care professional on 20 January 2012. This case involves 1 of a cluster of 4 patients who had received FLUZONE Intradermal (lot number UT4163AA) and experienced reactions. Information regarding the other 3 patients is captured in case numbers 2011-10556 (serious cases), 2012-00783 and 00785 (both non-serious cases). A 57 year-old female patient had received a left upper arm dose of FLUZONE Intradermal (lot number UT4163AA) on 21 December 2011 at 10:30 am and the following day experienced extensive swelling of the vaccinated limb. It was not reported whether the patient required any medical evaluation or treatment. The patient recovered on an unspecified date. Documents held by sender: None.
dizzy, trouble navigating, could not eat, dizziness progressed-could not walk;sx residing but not fully recovered; no sense of balance;
I got dizzy instantly, fast heart rate that came and went for two hours and then strong taste of rubbing alcohol that took over my nose and taste for 5 minutes after shot. My eyes burned for a few seconds only and my face felt like it was stinging for a few minutes. Mild swelling in face for two hours. It reversed my Covid long haul symptom and after weird strong alcohol smell I have full use of taste and smell. Not sure if it will last. I took a melatonin to help with calming down heart rate and that helped. This is just immediate reaction, but I can smell again!
Patient had no known side effects; expired dose of VAQTA that was administered to a patient; This spontaneous report was received from a registered nurse and refers to the patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided.  On 22-NOV-2021, the patient was vaccinated intramuscularly with 0.5 milliliter of hepatitis a virus inactivated [MRC-5 CELLS] (VAQTA) (lot # T013546, expiry date: 28-OCT-2021; site of administration and formulation were not reported) for prophylaxis (Expired product administered).   The reporter confirmed that the administered dose of hepatitis a virus inactivated [MRC-5 CELLS] (VAQTA) had not had any temperature excursions.   There was no adverse event reported.
SHOTS ADM ON TUESDAY3/3/20. ON SATURDAY PT C/O REDNESS AND ITCHING, FOLLOWED BY HIVES ON LT SHOULDER AREA. HIVES SUBSIDED, BUT STILL HAD REDNESS AND ITCHING WHEN PT RETURNED TO CLINIC  ON 3/10/2020 TO REPORT REACTION.
Headache, vomiting, chills, dizziness 24 hour bed rest and Tylenol 1/15/2021, still light headed and slightly dizzy
Sweating; Weakness; Chills; Fever; a persisting and uncomfortable itching at the left arm , where the vaccine was injected; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PRURITUS (a persisting and uncomfortable itching at the left arm , where the vaccine was injected) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0880853) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PRURITUS (a persisting and uncomfortable itching at the left arm , where the vaccine was injected). At the time of the report, HYPERHIDROSIS (Sweating), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PRURITUS (a persisting and uncomfortable itching at the left arm , where the vaccine was injected) had resolved.            Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: TCR: Updated all events Outcome from Unknown to Recovered/ Resolved
Twelve hours after vaccine had headache and fever.  Next morning Pt dizzy.  Pt was seen by clinic had temp of 101.3.  Mother had given TYLENOL 2 hours prior to evaluation.
On date of vaccination, started with fevers to 102 and ?delirious, then on 11/20/15 had lip swelling and eyelid swelling-treated with Benadryl, now presently with left arm swelling and redness.
On the day after the shot, I had a headache and fatigue, which I was expecting.  3 days after, I was having some feeling of being a little out of it - spaciness and some light headedness.  Although I would NOT classify it as a brain fog, I am switching words around regularly.  Very randomly.  My dreams are INCREDIBLY vivid.
Day of shot - sore arm all day  2pm day of shot - very exhausted 8pm - leg cramps + very exhausted  March 13 & 14 - very exhausted,  less sore arm  March 15 & 16 - dizzy, very exhausted, diarrhea,  chills, itchy arm March 17 side effects but milder March 18 side effects ended
Patient states that 30 minutes after receiving Rabavert, she noticed that her she had pain in her right eye. Patient states that redness occurred 1 hour after injection. Denies swelling, previous trauma, loss of vision, fever.
I had the same thing happen as 2nd dose. I went to bed at 8:00 that night and 3:30 AM I woke up with tachycardia at 130 and shaking and chills, but no cramps. This time I wasn't going to the ER so I toughed it out for 36 hours with Gatorade and Jello. No fever, and in 36 hours I was back to normal. No EKG this time.
Approximately 10:30 am patient had nausea and vomiting. Also, complained of numbness of lips, and was mildly diaphoretic. Denied any other symptoms. Vital signs at that time BP 134/70 HR 88 and O2 sat 98%. Patient states she was a little better after emesis. VS at 10:40am were  BP 120/77 HR 80 and O2 sat 98% with some improvement of symptoms.  At 10 :50 am VS were BP 100/55 HR 75 and O2 Sat 98%  and states she is feeling better and numbness in lips subsiding. At 11:02 am  VS 134/75 HR 68 and O2 Sat 98%. Patient states she felt better and was ready to be excused. She was advised to seek medical attention if symptoms returned or worsened. She verbalized an understanding and was released from clinic observation.
DOB 06/15/1990 female received Pfizer vaccine 1st dose at 1045, was observed for 15 minutes, no reaction noted. Post vaccine was rounding on floors when she began to feel ill and dizzy. Was brought back down to her department where she became unresponsive. Rapid Response was call and patient was taken to the ER at approximately 1:20 P.M. At 3:00 P.M. Patient remained in the ER pending discharge. Stated feeling well, dizziness had subsided and no longer feeling ill. States she had not eaten breakfast and had been experiencing stress
Severe headache from 12/30 0400 to 1/3/21, extreme fatigue, and excessive thirst
Patient given Moderna booster dose instead of required Bi Valent dose as required making the dose the fifth booster of of Moderna original formulation.
This is a spontaneous report from a contactable consumer. A 28-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 15Feb2021 to 15Feb2021 (Lot Number: EL3247, at the age of 28-years-old) as single dose for covid-19 immunization. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 25Jan2021 (Lot Number: EL3247) as single dose for COVID-19 immunization. The patient did not have known allergies. There were no concomitant medications. The patient experienced shortness of breath, nausea, vomiting, dizziness when going from a sitting to standing on 15Feb2021. The outcome of the events was not recovered.
A report was received from a healthcare professional concerning a 24 year old female. the vaccinee has a history of splenectomy and penicillin allergy and had no concomitant medications. On 10/27/06 the vaccinee was administered influenza virus vaccine (brand unspecified) at and unspecified site and Pneumovax 23 0.5 ml SC in her left arm. On the evening of 10/27/06 the vaccinee developed a cellulitis like reaction at the injection site. Her left arm became red, swollen and sore and she developed a fever. On 10/28/06 the vaccinee developed shortness of breath, was hospitalized, and diagnosed with cellulitis of the left arm. The vaccinee was treated with an unspecified antibiotic through a PICC line. her white cell count was 46.2 )no units provided) and blood cultures were neg. An MRI of the upper left arm was also performed (no results were provided). The vaccinee was hospitalized for 5 days, and by 11/14/06 she had fully recovered. The reporter considered the events to be serious, immediately life threatening and medically significant (OMIC). The vaccinee had been vaccinated with Pneumovax 23 five years ago with no reported reactions. Further information has been requested.
I just took the moderna vaccine yesterday 3FEB2021 and I am currently 7.5 weeks pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (I just took the moderna vaccine yesterday 3FEB2021 and I am currently 7.5 weeks pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 03-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (I just took the moderna vaccine yesterday 3FEB2021 and I am currently 7.5 weeks pregnant). On 03-Feb-2021, EXPOSURE DURING PREGNANCY (I just took the moderna vaccine yesterday 3FEB2021 and I am currently 7.5 weeks pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment medication details given.
felt really sick; chest pain; bad headache; it spiked blood pressure the very first day/Her blood pressure spiked the first day; This is a spontaneous report from contactable consumers (one is patient). A 64-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140), intramuscularly on left arm on 28Dec2020 at single dose for COVID-19 prophylaxis. The patient medical history included: Chronic hypertension and elevated cholesterol levels. Concomitant medication included ongoing acetylsalicylic acid (BABY ASPIRIN) for chronic hypertension and elevated cholesterol levels, then developed GI problems and she skipped days. On 28Dec2020 she received the 1st dose of the Pfizer vaccine. She was scheduled for her 2nd dose on 22Jan2021 (Friday). The patient developed a bad headache on 28Dec2020 that evening was better by the next morning then came back, it spiked my blood pressure the very first day, it usually responded to the medication but this time it didn't. The patient's blood pressure stayed like that for 2 to 3 days, she felt really sick on unknown date, on the 3rd day on 31Dec2020 the patient had some chest pain, but later that day she was feeling back to normal. Right now she felt fine, her blood pressure was back to my normal, baseline. Weight 153-154 lbs. Reporter said that what concerned her most was that her blood pressure spiked. She said that has never happened in the past that with her blood pressure before. Her blood pressure did not respond to her medication. The patient was trying to research the high blood pressure and hadn't been able to find any information and want to know if there was any information can provide. The patient wanted to take the vaccine, she just wanted to be sure she would be okay. The outcome of event headache was not recovered. The outcome of events blood pressure increased and chest pain was recovered on unknown date. The event of rest event was unknown.
Information has been received from a licensed practical nurse concerning an 82 year old female patient with allergy to lorazepam and a history of mastectomy who on 20-SEP-2010, was vaccinated in the arm with a dose of PNEUMOVAX 23 (Lot# 665924/0930Z). On the same day, the patient was vaccinated inn the same arm with a dose of FLUZONE. On 21-SEP-2010, the patient developed redness, swelling, fever and chills. On 22-SEP-2010, was started on KEFLEX and the symptoms resolved. Lab diagnostics studies were not performed. The patient sought medical attention. At the time of the report, the patient had recovered. Follow-up information has been received from a physician, who reported that female patient with rash at the time of vaccination on 20-SEP-2010 was vaccinated in the right arm with a dose of PNEUMOVAX 23 and flu vaccine, but the patient refused to have the vaccine in the right arm. She developed redness at the injection sites. At the time of the report the patient had recovered. The patient did not seek medical attention. Additional information is not expected.
RED RASH ON ARM ABOUT 5 INCHES IN LENGTH. STARTED ON 10/6 AND STILL PRESENT ON 10/9.
hurt for a week; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 22-AUG-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient got shingles injection for shingles and he/she was hurt for a week.  The reporter stated that, one more to go and he/she was then done. Additional Supportive Information: The follow up would not possible as no contact details were available.
This spontaneous report as received from a nurse refers to a 75 years old female patient Type 2 diabetes mellitus. the patient was vaccinated with, .65 ZOSTAVAX on 24-OCT-2012 in left arm. No other co-suspects were reported. Concomitant medications included: aspirin. On 26-OCt-2012 the patient experienced red bump, 4 mm in diameter around injection site, 3 days after onset of therapy, arm slightly swollen and pain shooting down arm. No treatment information was reported. The outcome of red bump, 4 mm in diameter around injection site, arm slightly swollen and pain shooting down arm was reported as recovering/resolving. The relatedness for red bump, 4 mm in diameter around injection site, arm slightly swollen and pain shooting down arm is unknown for ZOSTAVAX. Additional information has been requested.
Information has been received from a nurse concerning a 15 year old female patient with no relative medical history, drug reactions or allergies who in September 2008, was vaccinated IM with her first dose of GARDASIL (lot number and site not reported).  In December 2008, the patient was vaccinated IM with her second dose of GARDASIL (lot number and site not reported).  On 25-MAR-2009, the patient was vaccinated IM with her third dose of GARDASIL (lot number 661953/1130X), site not reported).  There was no concomitant medication.  On 27-MAR-2009 the patient developed allergic symptoms.  The patient developed shortness of breath and rash all over her body.  The event persisted at this report time.  The patient went to an emergency room to seek medical attention.  Additional information has been requested.
Excruciating and intense headaches that radiates to the neck/back that have been going on for almost a year. Additionally, burning sensation in head and face.
Nausea, vomitting, severe diahhrea. The diahrrea was for 25 days and was minimum 12 bouts per day. 2 different hospitals tested him for all known viruses, food borne illnesses, bacteria, parasites. They did an endoscope and colonoscopy. What they reported was "an allergy in the gut." He had damage in his gut.
Tachycardia, shortness of breath, slight chest pain, low grade fever, overall discomfort I
Fever 99 - 103 increase temp day of IZ's, Tuesday 101; Wednesday 99 - 102; Thursday 98 - 103 - 8pm, vomit x 2 vomited Wednesday am; Thursday pm.
Pts mom called our Urgent Care Clinic 2-21-06. Side effects hives/rash on wrist, hand and thigh toes and knees. Shot was administered to L arm. Pt used chewable Benadryl and hydrocortisone cream. No SOB. x3 days
SWEATING; BACK OF KNEES FEEL SWOLLEN AND PUFFY AND PILLOWY; CHILLS; LEG PAIN; FEVER; HEADACHE; NUMBNESS AND TINGLING IN BACK TO CALF/KNEE; ACHY; BLOATING; WATER RETENTION; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. The patient's past medical history included progressive macular hypomelanosis, and concurrent conditions included seasonal allergy, and hazelnut allergy/almond allergy, and other pre-existing medical conditions included patient had not pregnant at the time of reporting. The patient was previously treated with amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate for progressive macular hypomelanosis, and cetirizine hydrochloride for progressive macular hypomelanosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 041A21A, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced achy. On 12-APR-2021, the subject experienced bloating. On 12-APR-2021, the subject experienced water retention. On 12-APR-2021 19:00, the subject experienced numbness and tingling in back to calf/knee. On 12-APR-2021 19:00, the subject experienced sweating. On 12-APR-2021 19:00, the subject experienced back of knees feel swollen and puffy and pillowy. On 12-APR-2021 19:00, the subject experienced chills. On 12-APR-2021 19:00, the subject experienced leg pain. On 12-APR-2021 19:00, the subject experienced fever. On 12-APR-2021 19:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from leg pain, numbness and tingling in back to calf/knee, and back of knees feel swollen and puffy and pillowy, and the outcome of fever, chills, achy, headache, sweating, bloating and water retention was not reported. This report was non-serious.
Rash on back of hands.  Started in small area above thumb, spread to whole left hand (same side as injection), then to right hand.  Itching comes and goes.  Has no improved yet.  Whole body was itchy the day after the vaccine.  Lasted 1 day.